Results 71 to 80 of about 5,385 (167)

Can Elderly Patients with Peritoneal Metastasis Induced by Appendiceal or Colorectal Tumours Benefit from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?

Clinical Interventions in Aging, 2021
Sicheng Zhou,1,* Qiang Feng,1,* Jing Zhang,2 Haitao Zhou,1 Zheng Jiang,1 Jianwei Liang,1 Wei Pei,1 Qian Liu,1 Zhixiang Zhou,1 Xishan Wang1 1Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer ...
Zhou S, Feng Q, Zhang J, Zhou H, Jiang Z, Liang J, Pei W, Liu Q, Zhou Z, Wang X   +9 more
doaj  

HIPEC for ovarian cancer

, 2021
Eierstokkanker staat in de top 10 van kankerdiagnoses bij vrouwen wereldwijd. Ongeveer 70-80% van de patiënten met eierstokkanker, heeft deze ziekte in stadium III of IV, waarbij de ziekte is uitgezaaid naar het buikvlies of buiten de buikholte. De behandeling van eierstokkanker bestaat uit chirurgie, chemotherapie en doelgerichte onderhoudstherapie ...
openaire   +2 more sources

Small bowel obstruction and ovarian cancer: insights from a propensity-score matched study in patients with and without hyperthermic intraperitoneal chemotherapy after cytoreductive surgery

World Journal of Surgical Oncology
Background Small bowel obstruction (SBO) affects ~ 30% of ovarian cancer (OC) patients, leading to readmission, debilitating symptoms, and death within one year. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) effectively
Luis Felipe Falla-Zuniga, Armando Sardi, Mary Caitlin King, Felipe Lopez-Ramirez, Vladislav Kovalik, Sergei Iugai, Teresa Diaz-Montes, Vadim Gushchin   +7 more
doaj   +1 more source

Evaluation of the feasibility, safety, and preliminary effectiveness of hyperthermic intraperitoneal chemotherapy following radical surgery for locally advanced gastric cancer

Frontiers in Oncology
ObjectiveTo explore the feasibility, safety, and potential association between hyperthermic intraperitoneal chemotherapy (HIPEC) and peritoneal recurrence in patients with locally advanced gastric cancer following D2 radical surgery.Materials and ...
Tianze Zhang, Hang Yu, Lang Wang, Shijun Zhao, Cheng Zhao, Jie Chai, Dehai Wang   +6 more
doaj   +1 more source

Factors influencing hematological toxicity and adverse effects of perioperative hyperthermic intraperitoneal vs intraperitoneal chemotherapy in gastrointestinal cancer

Open Medicine
Intraperitoneal (IP) chemotherapy (IPC), including hyperthermic intraperitoneal chemotherapy (HIPEC), has emerged as a promising approach to control peritoneal metastases in gastrointestinal (GI) cancers. However, the safety profile and toxicity spectrum
Zhang Xue, Zheng Zhewen, Gao Hui, Yang Ziqi, Bai Jian   +4 more
doaj   +1 more source

Implementation of an enhanced recovery after surgery (ERAS) program in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: study protocol for a prospective multicenter interventional trial (EPICH study)

Pleura and Peritoneum
This study aims to evaluate the clinical impact of introducing an Enhanced Recovery After Surgery (ERAS) protocol in the management of patients undergoing cytoreductive surgery (CRS), with or without hyperthermic intraperitoneal chemotherapy (HIPEC).
Robella Manuela, Pagano Eva, Giacometti Lisa, Cinquegrana Armando, Pellegrino Luca, Evangelista Andrea, Saliva Alessandra, Cerutti Alessandro, Borghi Felice   +8 more
doaj   +1 more source

Construction of sensitive quality index system of perioperative nursing during hyperthermic intraperitoneal chemotherapy

Huli yanjiu
ObjectiveTo construct a sensitive quality indicators system for hyperthermic intraperitoneal chemotherapy（HIPEC），and provide a scientific tool for improving nursing quality.MethodsBased on the theoretical basis of "structure⁃process⁃outcome" quality ...
XIAO Xueying, HUANG Yulin, LI Yanmei, WANG Haoyun   +3 more
doaj  

HIPEC

Ovarian cancer is the third most common and deadliest gynecologic cancer. The lack of specific symptoms often leads to delayed diagnosis and advanced disease with extensive peritoneal metastases. Hyperthermic intraperitoneal chemotherapy (HIPEC) is a technique in which heated chemotherapy is delivered into the abdominal cavity after cytoreductive ...
openaire   +2 more sources

HIPEC στον καρκίνο του στομάχου

, 2021
Gastric cancer constitutes the third most common malignancy worldwide and the third most common cause of death due to malignancy. The incidence of the disease differs depending on the area, the race and the gender. The prognosis as well as the treatment options depend largely on the stage of the disease.
openaire   +1 more source

Treatment planning software for HIPEC

, 2023
Peritoneal metastases (PM) predominantly originate from primary cancers such as colorectal, ovarian and gastric cancer. Survival rates decrease dramatically when metastases develop in the peritoneal cavity. The combination of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) offers a treatment option that can ...
openaire   +2 more sources